Jasper Therapeutics (NASDAQ:JSPR) is a biotechnology company focused on revolutionizing bone marrow and hematopoietic cell transplantations with its cutting-edge technologies and innovative therapies. At the core of their operations, they aim to develop safer, more effective conditioning agents and stem cell engineering processes. Their projects are primarily aimed at treating a wide array of severe and life-threatening diseases, including certain cancers and genetic disorders, by enabling safer, more accessible transplant solutions. Jasper Therapeutics' overarching objective is to enhance patient outcomes and improve the quality of life for those undergoing bone marrow or stem cell transplants.